An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy
Clinical trial NCT00883753 · COMPLETED
Trial details
- NCT number
- NCT00883753
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2012-04-01
- Enrollment
- 934
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.